McKnight’s Senior Living August 9, 2022
Long-term care residents and other Medicare beneficiaries will not have to pay more than $2,000 per year for their medications, and beneficiaries with diabetes will not have to pay more than $35 per month for insulin, under the terms of the Inflation Reduction Act passed by the Senate over the weekend — if it also passes in the House as written and is signed into law as expected.
“Hitting some key areas [of the economy] such as impacts on senior pocketbooks in healthcare in particular is going to have a very positive outcome for seniors in how that translates into senior care,” Chris Orestis, CSA, president of Retirement Genius, told the McKnight’s Business Daily.
Keeping health insurance affordable is...
Today's Sponsors
Today's Sponsor